Covered recipient · General Payments record
ALLYSON JO SCHUMACHER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021
$221.18
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $221.18 | 18 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $140.86 | 13 |
| Janssen Pharmaceuticals, Inc | $29.69 | 2 |
| Amarin Pharma Inc. | $18.66 | 1 |
| JAZZ PHARMACEUTICALS INC. | $16.37 | 1 |
| Acerta Pharma LLC | $15.60 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $221.18 | 18 |
Payment records · PY2021 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $4.77 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456917 | CMS |
| AbbVie Inc. | $4.17 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456923 | CMS |
| AbbVie Inc. | $22.51 | 02/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456929 | CMS |
| AbbVie Inc. | $4.09 | 02/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456935 | CMS |
| AbbVie Inc. | $15.25 | 02/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456941 | CMS |
| AbbVie Inc. | $14.53 | 02/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456947 | CMS |
| AbbVie Inc. | $1.55 | 03/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456953 | CMS |
| AbbVie Inc. | $5.19 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456959 | CMS |
| AbbVie Inc. | $9.57 | 03/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456965 | CMS |
| AbbVie Inc. | $10.82 | 07/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456971 | CMS |
| AbbVie Inc. | $25.90 | 09/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456977 | CMS |
| AbbVie Inc. | $13.20 | 09/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456985 | CMS |
| AbbVie Inc. | $9.31 | 10/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795456991 | CMS |
| Amarin Pharma Inc. | $18.66 | 02/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815355437 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.60 | 03/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 829266527 | CMS |
| Janssen Pharmaceuticals, Inc | $14.69 | 01/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788087111 | CMS |
| Janssen Pharmaceuticals, Inc | $15.00 | 04/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788087109 | CMS |
| JAZZ PHARMACEUTICALS INC. | $16.37 | 01/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845630737 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.